The cabin stays climate-controlled
In the U.S., about 6% of adults currently use GLP-1s, and 12% have used them in the past (2024 data) (Mozafariun 2025)
History of Exeter, New Hampshire (Reprint ed.)
There is significant evidence that people with type 2 diabetes in the US, UK and worldwide do not intensify treatment, despite not achieving glycemic control targets, with concerns around potential side effects of therapies (such as weight gain and hypoglycemia) and fear of injection often cited as reasons for therapeutic inertia [18,19,20,21,22]
Saxagliptin stays in your body for less time than other gliptins and it doesnt get into the body easily when taken by mouth, so it is unlikely to transfer to your child in significant amounts